Paper5834403
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid.
Andersson L and 5 others. Scand J Haematol, 1965. Cited by 125 papers, by iCite.
Cite this record
ConductScience Library. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Papers, record 5834403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5834403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifibrinolytic Agents | Major topic |
| Hemorrhage | Major topic |
| Adult | |
| Aged | |
| Blood Proteins | |
| Child, Preschool | |
| Fibrinogen | |
| Humans | |
| Male | |
| Middle Aged | |
| Plasminogen | |
| Prostatectomy | |
| Streptodornase and Streptokinase | |
| Urine |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41939635 | Tranexamic Acid in Dacryocystorhinostomy: A Systematic Review. | Cureus | 2026 | https://conductscience.org/library/papers/41939635 | PubMed |
| 40412719 | High tranexamic acid concentrations alter fibrin network structure and biophysical properties. | J Thromb Haemost | 2025 | https://conductscience.org/library/papers/40412719 | PubMed |
| 37601774 | The effect of sequential perioperative intravenous tranexamic acid in reducing postoperative blood loss and hidden blood loss after posterior lumbar interbody fusion: a randomized controlled trial. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37601774 | PubMed |
| 37599607 | Tranexamic acid - a promising hemostatic agent with limitations: a narrative review. | Korean J Anesthesiol | 2024 | https://conductscience.org/library/papers/37599607 | PubMed |
| 36876075 | Antiproliferative activity of antimicrobial peptides and bioactive compounds from the mangrove Glutamicibacter mysorens. | Front Microbiol | 2023 | https://conductscience.org/library/papers/36876075 | PubMed |
| 36499270 | 1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499270 | PubMed |
| 36190062 | A randomized control trial on the role of tranexamic acid in preventing intraoperative bleeding during external dacryocystorhinostomy. | Indian J Ophthalmol | 2022 | https://conductscience.org/library/papers/36190062 | PubMed |
| 35408669 | Synthesis and Hemostatic Activity of New Amide Derivatives. | Molecules | 2022 | https://conductscience.org/library/papers/35408669 | PubMed |
| 34250266 | WOMAN-PharmacoTXA trial: Study protocol for a randomised controlled trial to assess the pharmacokinetics and pharmacodynamics of intramuscular, intravenous and oral administration of tranexamic acid in women giving birth by caesarean section. | Wellcome Open Res | 2021 | https://conductscience.org/library/papers/34250266 | PubMed |
| 32869162 | Efficacy of topical versus intravenous tranexamic acid in spinal deformity. | Eur Spine J | 2020 | https://conductscience.org/library/papers/32869162 | PubMed |
| 31624738 | The use of tranexamic acid in spine surgery. | Ann Transl Med | 2019 | https://conductscience.org/library/papers/31624738 | PubMed |
| 30715003 | Perioperative intravenous tranexamic acid reduces blood transfusion in primary cementless total hip arthroplasty. | Acta Biomed | 2019 | https://conductscience.org/library/papers/30715003 | PubMed |
| 30200059 | Is the combined application of both drain-clamping and tranexamic acid superior to the single use of either application in patients with total-knee arthroplasty?: A meta-analysis of randomized controlled trials. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30200059 | PubMed |
| 29662786 | Comparison of topical and intravenous administration of tranexamic acid for blood loss control during total joint replacement: Review of literature. | J Orthop Translat | 2018 | https://conductscience.org/library/papers/29662786 | PubMed |
| 29521284 | Additional Dose of Intravenous Tranexamic Acid after Primary Total Knee Arthroplasty Further Reduces Hidden Blood Loss. | Chin Med J (Engl) | 2018 | https://conductscience.org/library/papers/29521284 | PubMed |
| 28979607 | Application of Tranexamic Acid in Total Knee Arthroplasty - Prospective Randomized Trial. | Open Orthop J | 2017 | https://conductscience.org/library/papers/28979607 | PubMed |
| 27806184 | Antifibrinolytic therapy to reduce haemoptysis from any cause. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27806184 | PubMed |
| 27099820 | Systemic and Topical Use of Tranexamic Acid in Spinal Surgery: A Systematic Review. | Global Spine J | 2016 | https://conductscience.org/library/papers/27099820 | PubMed |
| 26420938 | Tranexamic acid reduces blood loss and need of blood transfusion in total knee arthroplasty: A prospective, randomized, double-blind study in Indian population. | Asian J Transfus Sci | 2015 | https://conductscience.org/library/papers/26420938 | PubMed |
| 26345147 | Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence. | J Blood Med | 2015 | https://conductscience.org/library/papers/26345147 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5834403
GET https://conductscience.org/api/papers/v1/5834403/cited_by?page=2